Optibrium develops exceptional software and AI solutions that help scientists advance their discovery projects. Cutting-edge science, backed up by rigorous research, underpins their intuitive software for compound design, optimisation and data analysis. Optibrium’s comprehensive in silico platform improves the speed, efficiency, and productivity of the discovery process and supports a worldwide customer base, including leading pharma, biotech, agrochemical and flavouring companies and not-for-profit and academic groups. Optibrium was founded in 2009 and is headquartered in Cambridge, UK, with a US subsidiary, Optibrium Inc., based in Cambridge MA. For further information, visit www.optibrium.com.

Trusted by over one million active users, Chemaxon is renowned for industry-leading software supporting scientific discovery with calculation, search and drawing tools. Our applications are widely used in life sciences R&D and education. We work with a variety of industries, counting most major pharmaceutical companies among our clients. Our offices are located in Budapest, Basel, Boston and San Diego, with distributors around the world.

Automation and digitalization of lab and entire product development workflows! Rooted in science, Chemspeed’s automation platforms, digital solutions and application expertise are used everyday in the top R&D and QC labs across the globe. Chemspeed is the leading provider of high throughput and high output research & development and quality control workflow solutions - from single bench-top / standalone automated workstations to fully automated, integrated, partial / entire product development workflows across the entire range of industries and academia. We are scientists at heart - we know what scientists need and we design our systems with this deep understanding at the core of each project.

Pivot Park Screening Centre is a Dutch company that offers services in assay development, lab automation, ultra-High Throughput Screening (uHTS), High Content Screening and hit-to-lead profiling, in order to find novel hits for drug development. We develop and miniaturize high-quality cellular, biochemical and biophysical primary, deselection, orthogonal and selectivity assays across various target classes and disease areas, and have carried out over 300 full-deck uHTS campaigns across libraries ranging ~0.3-1.5 million compounds, using label-based and label-free (MALDI-MS) readouts, mostly in 1,536-well plate format. You can either bring your own compound library or use our 300K IP-free druglike compound library.

Sable Bio specializes in drug target safety using data and AI, delivering comprehensive safety reporting for any drug target. We offer precise, relevant and actionable insights for safer and more effective drug development.

XtalPi is a global technology platform company powered by artificial intelligence (AI) and robotics. Founded in 2015, XtalPi is dedicated to driving intelligent and digital transformation in life sciences and discovering better therapeutics and new materials. By integrating and synergizing quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of innovative solutions, services, and products to empower our partners in the biopharmaceutical, chemical, new energy, and new materials sectors worldwide.

Arctoris is a tech-enabled Partnership Research Organization (PRO) headquartered in Oxford. We combine our unique automation platform, Ulysses, with a world-class team of excellent laboratory scientists to guide and rapidly progress our partners’ drug discovery programs from target to candidate. Data is the lifeblood of research, and “Better Data leads to Better Decisions”. Our excellent service is built on: 1) Data quality: generating large reproducible datasets by leveraging robotics and wet lab automation, in turn empowering improved decision-making. 2) Our world-class team of experienced scientists: a true partner for your discovery work, consulting and advising on assay cascades and the path from target all the way to the clinic. 3) An "ecosystem of excellence”: we are a full-suite discovery PRO with partners in all adjacent disciplines, which allows us to stay agile and truly client-focused. SpiroChem AG, headquartered in Basel, Switzerland, is a leading Contract Research Organization (CRO) specializing in complex discovery and early development chemistry. Renowned for tackling intricate synthetic challenges, SpiroChem supports global pharmaceutical companies, biotechs, CDMOs, and research institutes by delivering bespoke chemical solutions. The company’s innovative edge is highlighted by its proprietary CMRT macrocycle technology and the Quest™ and vQUEST™ libraries, featuring over 8,000 ready-to-screen macrocycles and an extensive virtual space of more than 100 million structures. These platforms enable precise pharmacophoric embedding, aiding in the rapid discovery of novel molecules. SpiroChem’s expertise extends to its advanced parallel synthesis platform, capable of performing a large range of useful chemical transformations, including cutting-edge techniques like photoredox catalysis. This versatile system supports high-throughput synthesis and efficient reaction optimization, essential for drug discovery and process development. Equipped with top-tier analytical tools, such as high-resolution mass spectrometry and automated NMR, SpiroChem ensures high purity and robust data. Its Chemistry Full-Time Equivalent (FTE) service model provides flexible project management by PhD-level leaders, ensuring customized client solutions. With a strong commitment to continuous innovation and automation, SpiroChem remains the trusted partner for complex chemical challenges, delivering unparalleled expertise and productivity.

Sponsor biography coming soon

Sponsor biography coming soon

Brooks Automation's PreciseFlex collaborative robots are the leader in Laboratory automation. Whether you need to tend an analyzer with microtiter plates, manage tubes into a process, or just about any other type of labware, Brooks can help Automate your workflow. Brooks is interested in understanding your Lab Automation challenges so that we can support and develop solutions along with our many OEM and Integration partners.

Cherry Biotech is a biomedical technology (Organ on Chip) company that develops instruments for drug discovery and personalised medicine. Its mission is to replace animal testing by reconstructing human tissue (Organoids) in vitro for drug testing. Cherry Biotech's CUBIX platform enables pharmaceutical, biotech companies and healthcare providers to recreate immunocompetent human vascularized organ models and tumor microenvironments for better evaluation of their drug candidates. By enabling the reconstruction of human 3D models that mimic human physiology and pathophysiology over several weeks, Cherry Biotech's proprietary CUBIX technology is the only solution that can convert a standard 2D multi-well plate into a 3D cell culture (Organ on Well). This innovative patented technology allows for the implementation of the current regulatory change on the ethics of animal experimentation while remaining compatible with the current industry workflow.

Concept Life Sciences, a collaborative client-centred approach. We are a multi-disciplined Contract Research Organisation based in the UK providing market-leading scientific services globally. Over the past 25 years, Concept Life Sciences and its heritage companies have played a pivotal role in guiding numerous clients along their path to clinical success and many of these clients have evolved into enduring scientific collaborators. Within a decade, the collaborative efforts of experts from our heritage businesses — Peakdale Molecular, CXR Biosciences, and Aquila Biomedical — have propelled us beyond the cumulative impact of our individual components, fostering substantial growth and advancement. We are based across 4 research sites in the UK delivering discovery research, as well as GMP, GLP, and GCP-regulated work. Whether it is delivering whole programs of research, or bespoke studies, we deliever a a collaborative client-centred approach. Our services include discovery chemistry, specialist translational biology for immunology, oncology and neuroscience, biologics, biophysical assays services, ADMET & DMPK, bioanalysis, toxicology, histology, analytical services, including materials characterisation and physiochemical analysis, process research and development, and GMP manufacturing.